← All trials
NCT02694783
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 19, 2016
- Primary completion
- Feb 15, 2018
- Completion date
- Feb 15, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 72
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Neurological Disorders and Stroke (NINDS)Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.